Cite
A retrospective, cohort-based survey of patients using twice-daily indinavir + ritonavir combinations: pharmacokinetics, safety, and efficacy
MLA
Burger, David M., et al. “A Retrospective, Cohort-Based Survey of Patients Using Twice-Daily Indinavir + Ritonavir Combinations: Pharmacokinetics, Safety, and Efficacy.” Journal of Acquired Immune Deficiency Syndromes (1999), vol. 26, no. 3, Mar. 2001, p. 218. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.73003292&authtype=sso&custid=ns315887.
APA
Burger, D. M., Hugen, P. W. H., Aarnoutse, R. E., Dieleman, J. P., Prins, J. M., Poll, T. van der, Veen, J. H. ten, Mulder, J. W., Meenhorst, P. L., Blok, W. L., Meer, J. T. M. van der, Reiss, P., & Lange, J. M. A. (2001). A retrospective, cohort-based survey of patients using twice-daily indinavir + ritonavir combinations: pharmacokinetics, safety, and efficacy. Journal of Acquired Immune Deficiency Syndromes (1999), 26(3), 218.
Chicago
Burger, David M., Patricia W.H. Hugen, Rob E. Aarnoutse, Jeanne P. Dieleman, Jan M. Prins, Tom van der Poll, Jacob H. ten Veen, et al. 2001. “A Retrospective, Cohort-Based Survey of Patients Using Twice-Daily Indinavir + Ritonavir Combinations: Pharmacokinetics, Safety, and Efficacy.” Journal of Acquired Immune Deficiency Syndromes (1999) 26 (3): 218. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.73003292&authtype=sso&custid=ns315887.